October 13th, 1995

Attention Deficit Disorder: A Dubious Diagnosis?

ADD: A Dubious Diagnosis?

Is A.D.D. real? Strong evidence indicates that the epidemic of Attention Deficit Disorder affecting mostly white, middle class boys is to a large extent man-made, one result of a long-term, unpublicized financial relationship between the company that makes the most widely known A.D.D. medication and the nation’s largest “A.D.D. Support Group.”

No question that A.D.D. is spreading, along with the use of powerful psychostimulants. The number of children being medicated-now an estimated 2,000,000-seems to be doubling every two years.

In preparing our 1995 documentary, we heard time and again that Ritalin is “all over the schools.” Recovering drug addicts told us that Ritalin was becoming what’s called a “gateway drug,” the first drug a child tries. And addicts told us that some teenagers snort Ritalin for a quick, cheap (but dangerous) high.

The Federal Drug Enforcement Administration reported that a Virginia teenager died from snorting Ritalin. We hope our documentary will help parents and educators find alternatives to unnecessary labels and powerful drugs-like smaller classes, more interesting curricula, and more personal attention at home and in school.

This provocative documentary helps parents and educators find alternatives to unnecessary labels and powerful drugs.

The program was awarded a First Place EWA award in 1995, and received a Certificate of Merit at the Western Psychological Association Film Festival in 1997.

Read a recent update from John Merrow on this issue.

(Originally aired October 1995)

   Print    Email    comments (0)

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading ... Loading ...




Comment Policy
Names are displayed with all comments, but email addresses remain private. Keep it brief, civil and on topic. Please note that Learning Matters reserves the right to edit comments for brevity and delete inappropriate or malicious comments. Please read the comment guidelines for more information.

Submit

SUBSCRIBE TO THE NEWSLETTER
FacebookYouTubeiTunesTwitter